Brazil Suspends Pharma Serialization And Tracing Requirements

Last week, Brazil’s pharma industry regulatory agency, the National Agency of Sanitary Surveillance (ANVISA), announced that they were “suspending” at least part of RDC-54/2013, the declaration that mandated drug serialization and tracing, until further notice.  Thank you to all who forwarded the link to the official announcement.  I was able to translate and read it on Thursday, and

Looking for Serialization & Tracing Insights?

To get full access to this and other great RXTRACE_LOGO_Trans_250x94 essays, you need to
either Login, or upgrade your current subscription!
 Unlimited access is just a few clicks away!
To learn why RXTRACE_LOGO_Trans_250x94 is such a great value, click here.









One thought on “Brazil Suspends Pharma Serialization And Tracing Requirements”

  1. This is nothing but waste of time. What we need is a global standard and not something specific to a country. It is a consultant’s cash cow in the name of medical safety and counterfeiting.

    Does not make sense for any company to invest time, money and resources.I am out at-least for now!

Comments are closed.